{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:47:35Z","timestamp":1791100055304,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/md.0000000000000011","type":"journal-article","created":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T17:19:18Z","timestamp":1388423958000},"page":"1-10","source":"Crossref","is-referenced-by-count":45,"title":["Inflammatory Arthritis in Patients With Myelodysplastic Syndromes"],"prefix":"10.1097","volume":"93","author":[{"given":"Ars\u00e8ne","family":"Mekinian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Decaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Falgarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Toussirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Raffray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Omouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gombert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"De Wazieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Buchdaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Ziza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Madaule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Grignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210226","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2141.2011.08683.x","article-title":"Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.","volume":"153","author":"Aggarwal","year":"2011","journal-title":"Br J Haematol"},{"key":"R2-1-20210226","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of RheumatologyEuropean League Against Rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R3-1-20210226","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.leukres.2010.12.015","article-title":"Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cells.","volume":"35","author":"Al Ustwani","year":"2011","journal-title":"Leuk Res"},{"key":"R4-1-20210226","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R5-1-20210226","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3324\/haematol.2011.044347","article-title":"Value of infliximab (Remicade) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group.","volume":"97","author":"Baron","year":"2012","journal-title":"Haematologica"},{"key":"R6-1-20210226","first-page":"95","article-title":"Joint manifestations in myelodysplastic syndromes. A report of three cases presenting as polymyalgia rheumatica.","volume":"64","author":"Berthelot","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"R7-1-20210226","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0248-8663(01)00367-8","article-title":"Myelodysplasias and systemic diseases. A non-fortuitous association.","volume":"22","author":"Berthier","year":"2001","journal-title":"Rev Med Interne"},{"key":"R8-1-20210226","first-page":"276","article-title":"RS3PE syndrome: an acute edematous polyarthritis of the elderly with variable prognosis.","volume":"152","author":"Beyne-Rauzy","year":"2001","journal-title":"Ann Med Interne (Paris)"},{"key":"R9-1-20210226","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.1995.tb00231.x","article-title":"Immune-mediated complications in patients with myelodysplastic syndromesclinical and cytogenetic features.","volume":"55","author":"Billstrom","year":"1995","journal-title":"Eur J Haematol"},{"key":"R10-1-20210226","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.revmed.2005.06.012","article-title":"Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients).","volume":"26","author":"Bouali","year":"2005","journal-title":"Rev Med Interne"},{"key":"R11-1-20210226","first-page":"539","article-title":"Polyarthritis associated with myelodysplastic syndromes.","volume":"196","author":"Carvajal Mendez","year":"1996","journal-title":"Rev Clin Esp"},{"key":"R12-1-20210226","first-page":"721","article-title":"Rheumatic manifestations in myelodysplastic syndromes.","volume":"18","author":"Castro","year":"1991","journal-title":"J Rheumatol"},{"key":"R13-1-20210226","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1445-5994.1996.tb02940.x","article-title":"Rheumatic manifestations of the myelodysplastic syndromes: a comparative study.","volume":"26","author":"Chandran","year":"1996","journal-title":"Aust N Z J Med"},{"key":"R14-1-20210226","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood"},{"key":"R15-1-20210226","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/38.4.373","article-title":"Seronegative oligoarthritis in the course of refractory anaemia with excess blasts.","volume":"38","author":"Cuende","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"R16-1-20210226","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/acr.20504","article-title":"Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study.","volume":"63","author":"de Hollanda","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R17-1-20210226","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","article-title":"Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.","volume":"91","author":"Enright","year":"1995","journal-title":"Br J Haematol"},{"key":"R18-1-20210226","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.23085","article-title":"Vasculitides associated with malignancies: analysis of sixty patients.","volume":"57","author":"Fain","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R19-1-20210226","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.revmed.2010.08.005","article-title":"Systemic and autoimmune manifestations in myelodysplastic syndromes.","volume":"32","author":"Fain","year":"2011","journal-title":"Rev Med Interne"},{"key":"R20-1-20210226","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0049-0172(92)90035-C","article-title":"Seronegative inflammatory arthritis in the myelodysplastic syndromes.","volume":"21","author":"George","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"R21-1-20210226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000083454","article-title":"Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion.","volume":"113","author":"Giagounidis","year":"2005","journal-title":"Acta Haematol"},{"key":"R22-1-20210226","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/rheumatology\/keh136","article-title":"Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.","volume":"43","author":"Giannouli","year":"2004","journal-title":"Rheumatology"},{"key":"R23-1-20210226","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes.","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"R24-1-20210226","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/39.4.417","article-title":"Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study.","volume":"39","author":"Hamidou","year":"2000","journal-title":"Rheumatology"},{"key":"R25-1-20210226","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0248-8663(96)80810-1","article-title":"Systemic diseases in myelodysplastic syndromes.","volume":"16","author":"Hebbar","year":"1995","journal-title":"Rev Med Interne"},{"key":"R26-1-20210226","first-page":"629","article-title":"Remitting seronegative symmetrical synovitis with pitting edema: a rheumatic manifestation of myelodysplastic syndrome Rev Rhum Engl Ed.","volume":"63","author":"Hernandez-Beriain","year":"1996","journal-title":""},{"key":"R27-1-20210226","first-page":"792","article-title":"Polymyalgia rheumatica in patients with myelodysplastic syndromes.","volume":"23","author":"Hubscher","year":"1996","journal-title":"J Rheumatol"},{"key":"R28-1-20210226","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/rheumatology\/26.6.458","article-title":"Lymphoreticular malignancy and monoclonal gammopathy presenting as polymyalgia rheumatica.","volume":"26","author":"Kalra","year":"1987","journal-title":"Br J Rheumatol"},{"key":"R29-1-20210226","first-page":"1446","article-title":"Myelodysplasia presenting as monoarthritis.","volume":"24","author":"Kaufman","year":"1997","journal-title":"J Rheumatol"},{"key":"R30-1-20210226","first-page":"1357","article-title":"An association of polymyalgia rheumatica with myelodysplastic syndromes.","volume":"21","author":"Kohli","year":"1994","journal-title":"J Rheumatol"},{"key":"R31-1-20210226","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000208236","article-title":"Sideroblastic anaemia presenting as monoarticular arthritis.","volume":"52","author":"Kumar","year":"1974","journal-title":"Acta Haematol"},{"key":"R32-1-20210226","first-page":"1649","article-title":"Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases.","volume":"21","author":"Kuzmich","year":"1994","journal-title":"J Rheumatol"},{"key":"R33-1-20210226","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1002\/cncr.25983","article-title":"Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia.","volume":"117","author":"Lee","year":"2011","journal-title":"Cancer"},{"key":"R34-1-20210226","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/PL00011192","article-title":"Remitting seronegative symmetrical synovitis with pitting oedema in a patient with myelodysplastic syndrome and relapsing polychondritis.","volume":"20","author":"Manganelli","year":"2001","journal-title":"Clin Rheumatol"},{"key":"R35-1-20210226","first-page":"2292","article-title":"Arthritis in a case of myelodysplastic syndromes.","volume":"29","author":"Mimura","year":"1988","journal-title":"Rinsho Ketsueki"},{"key":"R36-1-20210226","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/rheumatology\/35.5.496","article-title":"Polymyalgia rheumatica as the rheumatological manifestation of myelodysplastic syndrome in a Chinese patient.","volume":"35","author":"Mok","year":"1996","journal-title":"Br J Rheumatol"},{"key":"R37-1-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2141.1986.tb07504.x","article-title":"Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies.","volume":"63","author":"Mufti","year":"1986","journal-title":"Br J Haematol"},{"key":"R38-1-20210226","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3346\/jkms.1999.14.3.319","article-title":"Rheumatoid arthritis associated with myelodysplastic syndrome: a case report.","volume":"14","author":"Nam","year":"1999","journal-title":"J Korean Med Sci"},{"key":"R39-1-20210226","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00296-007-0445-z","article-title":"Successful treatment using tacrolimus plus corticosteroids in a patient with RA associated with MDS.","volume":"28","author":"Nozaki","year":"2008","journal-title":"Rheumatol Int"},{"key":"R40-1-20210226","first-page":"333","article-title":"The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. The Catalan Group for the Study of RS3PE.","volume":"24","author":"Olive","year":"1997","journal-title":"J Rheumatol"},{"key":"R41-1-20210226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/PL00011218","article-title":"Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases.","volume":"21","author":"Paira","year":"2002","journal-title":"Clin Rheumatol"},{"key":"R42-1-20210226","first-page":"11","article-title":"Rheumatological manifestations associated with myelodysplastic and myeloproliferative syndromes.","volume":"59","author":"Pajus","year":"1992","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"R43-1-20210226","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00124743-199504000-00013","article-title":"Leukemic synovitis as the cause of arthritis in myelodysplastic syndrome.","volume":"1","author":"Pando","year":"1995","journal-title":"J Clin Rheumatol"},{"key":"R44-1-20210226","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2141.2010.08557.x","article-title":"The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases.","volume":"153","author":"Pilorge","year":"2011","journal-title":"Br J Haematol"},{"key":"R45-1-20210226","first-page":"S31","article-title":"A case of arthritis and vasculitis associated with the refractory anemia with excess of blasts syndrome resistant to glucocorticoids treatment that responded favorably to TNF-alpha blockade.","volume":"24","author":"Pipitone","year":"2006","journal-title":"Clin Experimental Rheum"},{"key":"R46-1-20210226","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1297-319X(02)00378-0","article-title":"Myelodysplasia revealed by seropositive polyarthritis complicated by bicytopenia after the first methotrexate dose.","volume":"69","author":"Soubrier","year":"2002","journal-title":"Joint Bone Spine"},{"key":"R47-1-20210226","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:36:41Z","timestamp":1620959801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201401000-00001"}},"subtitle":["A Multicenter Retrospective Study and Literature Review of 68 Cases"],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000011","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}